Catabasis raising $20.4M; modulates multiple disease pathways for Duchenne muscular dystrophy, ALS
Multiple biological pathways go awry to cause disease. Cambridge startup Catabasis is developing a platform to simultaneously modulate multiple targets in a disease pathway, with a focus on diseases like Duchenne muscular dystrophy and ALS The startup’s in the midst of a $20.4 million fundraise, according to a recent SEC filing. So far, it’s raised about […]